Biblioteca Humberto Rosselli Quijano
[artículo]
Título : |
Phase IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group |
Tipo de documento: |
texto impreso |
Autores: |
Guy Chouinard, Autor |
Fecha de publicación: |
2022 |
Artículo en la página: |
pp. 1018–1025 |
Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
Palabras clave: |
Antipsicóticos, Enfermedad crónica, Examen neurológico, Risperidona, Esquizofrenia, Psicología esquizofrénica |
Resumen: |
Since most clinical trials of atypical antipsychotics have been conducted in hospitalized patients, a Phase-IV, multicentre, 8-week, open-label, flexible-dose study was performed to assess the efficacy and safety of risperidone in outpatients with schizophrenia. |
Link: |
./index.php?lvl=notice_display&id=29170 |
in The Canadian Journal of Psychiatry > Año 1998 Vol. 43 - No. 10 (Diciembre) . - pp. 1018–1025
[artículo] Phase IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group [texto impreso] / Guy Chouinard, Autor . - 2022 . - pp. 1018–1025. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The Canadian Journal of Psychiatry > Año 1998 Vol. 43 - No. 10 (Diciembre) . - pp. 1018–1025
Palabras clave: |
Antipsicóticos, Enfermedad crónica, Examen neurológico, Risperidona, Esquizofrenia, Psicología esquizofrénica |
Resumen: |
Since most clinical trials of atypical antipsychotics have been conducted in hospitalized patients, a Phase-IV, multicentre, 8-week, open-label, flexible-dose study was performed to assess the efficacy and safety of risperidone in outpatients with schizophrenia. |
Link: |
./index.php?lvl=notice_display&id=29170 |
|